Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-24-006398
Filing Date
2024-05-15
Accepted
2024-05-15 16:07:15
Documents
47
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q drma_10q.htm   iXBRL 10-Q 551061
2 CERTIFICATION drma_ex311.htm EX-31.1 8856
3 CERTIFICATION drma_ex312.htm EX-31.2 8873
4 CERTIFICATION drma_ex321.htm EX-32.1 5552
  Complete submission text file 0001654954-24-006398.txt   3038678

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA drma-20240331.xsd EX-101.SCH 34844
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20240331_lab.xml EX-101.LAB 196937
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20240331_cal.xml EX-101.CAL 23338
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20240331_pre.xml EX-101.PRE 171257
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20240331_def.xml EX-101.DEF 115356
51 EXTRACTED XBRL INSTANCE DOCUMENT drma_10q_htm.xml XML 422279
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40739 | Film No.: 24950516
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)